Speaking Engagement: Delivered Keynote at the 10th Cell Manufacturing Kotozukuri Symposium
On March 4, 2026, Epistra Inc. CEO Yosuke Ozawa delivered a keynote speech at the “10th Cell Manufacturing Kotozukuri Symposium,” held at the Osaka University Graduate School of Medicine and Engineering Tokyo Branch in Nihonbashi, Tokyo.
Symposium Overview
This symposium is an annual event hosted by the Cell Manufacturing Kotozukuri Center at Osaka University. This edition was held under the theme “Information Utilization in Cell Manufacturing,” welcoming 95 participants. The event opened with an address from Mr. Shoki Nishio of the Ministry of Economy, Trade and Industry’s Bio and Chemical Industries Division, followed by an explanation of the theme’s fundamental concepts by Professor Kinooka, the center director.
Keynote Speech
Our CEO Ozawa spoke about optimizing cell manufacturing processes using AI and robotics. The speech was one of three keynote presentations, and numerous questions were raised from the floor, leading to active discussions.
Other keynote speakers included Professor Ryuji Kato of Nagoya University Graduate School of Pharmaceutical Sciences, who spoke about information utilization in quality control using image analysis, and Dr. Shinichi Sakurada of AI Biomedical Inc., who presented on next-generation cell manufacturing processes using AI and digital twins.
Growing Data-Driven Approaches in Cell Manufacturing
The symposium featured presentations on diverse information utilization efforts including image analysis, AI optimization, digital twins, and simulation. It was a venue that highlighted the strong interest in data-driven approaches within the cell manufacturing field.
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.